WELL Health Technologies Crescita futura

Future criteri di controllo 4/6

Si prevede che WELL Health Technologies aumenterà gli utili e i ricavi rispettivamente del 25.6% e 17.7% all'anno, mentre si prevede che l'EPS crescerà del 30.2% all'anno.

Informazioni chiave

25.6%

Tasso di crescita degli utili

30.2%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	59.4%
Tasso di crescita dei ricavi	17.7%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Good
Ultimo aggiornamento	28 Apr 2025

Aggiornamenti recenti sulla crescita futura

Recent updates

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Apr 23

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Apr 22

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Apr 01

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

Mar 29

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

Jan 19 Market consolidation and clinic efficiency initiatives could significantly enhance WELL Health's revenue growth and net margins.

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Dec 31

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

Nov 29

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Nov 11

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Sep 09

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Jul 05

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

Jun 11

Previsioni di crescita degli utili e dei ricavi

TSX:WELL - Stime future degli analisti e dati finanziari passati (CAD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2027	1,722	81	N/A	197	5
12/31/2026	1,531	54	89	154	13
12/31/2025	1,370	25	82	118	14
12/31/2024	920	33	-17	10	N/A
9/30/2024	958	73	112	127	N/A
6/30/2024	910	147	67	89	N/A
3/31/2024	838	30	49	68	N/A
12/31/2023	776	0	41	66	N/A
9/30/2023	701	-7	60	81	N/A
6/30/2023	643	-4	61	76	N/A
3/31/2023	612	-5	67	81	N/A
12/31/2022	569	1	70	77	N/A
9/30/2022	528	-29	20	56	N/A
6/30/2022	482	-37	5	49	N/A
3/31/2022	403	-45	-19	34	N/A
12/31/2021	302	-44	-30	22	N/A
9/30/2021	204	-29	-13	10	N/A
6/30/2021	117	-21	-10	2	N/A
3/31/2021	66	-9	-4	-4	N/A
12/31/2020	50	-4	-7	-5	N/A
9/30/2020	43	-9	-5	-4	N/A
6/30/2020	39	-10	-4	-3	N/A
3/31/2020	36	-8	-4	-3	N/A
12/31/2019	33	-8	-3	-3	N/A
12/31/2018	9	-2	-1	-1	N/A
10/31/2018	6	-2	N/A	-1	N/A
7/31/2018	4	-6	N/A	-1	N/A
4/30/2018	2	-6	N/A	-1	N/A
1/31/2018	0	-6	N/A	-1	N/A
10/31/2017	N/A	-1	N/A	-1	N/A
7/31/2017	0	-1	N/A	-1	N/A
3/31/2017	0	0	N/A	-1	N/A
12/31/2016	0	0	N/A	0	N/A
10/31/2016	0	-1	N/A	0	N/A
12/31/2015	0	-1	N/A	0	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di WELL ( 25.6% all'anno) è superiore al tasso di risparmio ( 2.4% ).

Guadagni vs Mercato: Si prevede che gli utili di WELL ( 25.6% all'anno) cresceranno più rapidamente del mercato Canadian ( 16.5% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di WELL cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di WELL ( 17.7% all'anno) crescerà più rapidamente del mercato Canadian ( 4.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di WELL ( 17.7% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Dati insufficienti per determinare se il Return on Equity di WELL è previsto essere elevato tra 3 anni

Scoprire le aziende in crescita

Analisi aziendale e situazione dei dati finanziari

Dati	Ultimo aggiornamento (ora UTC)
Analisi dell'azienda	2025/05/01 01:01
Prezzo dell'azione a fine giornata	2025/05/01 00:00
Guadagni	2024/12/31
Guadagni annuali	2024/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

Pacchetto	Dati	Tempistica	Esempio Fonte USA ^*
Dati finanziari della società	10 anni	Conto economico Rendiconto finanziario Bilancio	Modulo SEC 10-K Modulo SEC 10-Q
Stime di consenso degli analisti	+3 anni	Previsioni finanziarie Obiettivi di prezzo degli analisti	Rapporti di ricerca degli analisti Blue Matrix
Prezzi di mercato	30 anni	Prezzi delle azioni Dividendi, scissioni e azioni	Dati di mercato ICE Modulo SEC S-1
Proprietà	10 anni	Top azionisti Insider trading	Modulo 4 SEC Modulo 13D SEC
Gestione	10 anni	Team di leadership Consiglio di amministrazione	Modulo SEC 10-K Modulo SEC DEF 14A
Sviluppi principali	10 anni	Annunci aziendali	Modulo 8-K SEC

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

WELL Health Technologies Corp. è coperta da 15 analisti. 14 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

Analista	Istituzione
Gabriel Leung	Beacon Securities Limited
Douglas Taylor	Canaccord Genuity
Scott Fletcher	CIBC Capital Markets

WELL Health Technologies Crescita futura

Future criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Consensus revenue estimates increase by 15%

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

Price target increased by 8.9% to CA$8.37

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

Recent updates

Impressive Earnings May Not Tell The Whole Story For WELL Health Technologies (TSE:WELL)

Upgrade: Analysts Just Made A Captivating Increase To Their WELL Health Technologies Corp. (TSE:WELL) Forecasts

Consensus revenue estimates increase by 15%

Full year 2024 earnings: EPS and revenues miss analyst expectations

WELL Health Technologies Corp. Provides Earnings Guidance for 2025

WELL Health Technologies Corp., Annual General Meeting, Jun 19, 2025

WELL Health Technologies Corp. to Report Q4, 2024 Results on Apr 14, 2025

WELL Health Technologies Corp. (TSE:WELL) Might Not Be As Mispriced As It Looks After Plunging 28%

Investor sentiment deteriorates as stock falls 21%

Are Investors Undervaluing WELL Health Technologies Corp. (TSE:WELL) By 45%?

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Microquest Inc

Independent Director exercised options and sold CA$198k worth of stock

AI-Driven Tools And Acquisitions Will Streamline Operations But Profit Margins May Decline

These 4 Measures Indicate That WELL Health Technologies (TSE:WELL) Is Using Debt Reasonably Well

Price target increased by 8.9% to CA$8.37

Investor sentiment improves as stock rises 23%

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

A Piece Of The Puzzle Missing From WELL Health Technologies Corp.'s (TSE:WELL) 27% Share Price Climb

When Should You Buy WELL Health Technologies Corp. (TSE:WELL)?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

WELL Health Technologies Corp. (TSX:WELL) entered into definitive agreement to acquire Canadian Clinical Assets of Jack Nathan Health from Jack Nathan Medical Corp. (TSXV:JNH) for CAD 5 million.

WELL Health Technologies Corp. to Report Q3, 2024 Results on Nov 07, 2024

Ms. CHAU Hoi Shuen Solina Holly acquired a 7.53% stake in WELL Health Technologies Corp. (TSX:WELL) for CAD 81.01 million.

Is WELL Health Technologies (TSE:WELL) A Risky Investment?

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

WELL Health Technologies Corp. Revised Revenue Guidance for the Year 2024

Consensus EPS estimates increase by 827%

Consensus EPS estimates fall by 13%

WELL Health Technologies Corp. to Report Q2, 2024 Results on Aug 14, 2024

Market Participants Recognise WELL Health Technologies Corp.'s (TSE:WELL) Revenues Pushing Shares 30% Higher

Chief Operating Officer exercised options to buy CA$1.6m worth of stock.

New major risk - Revenue and earnings growth

WELL Health Technologies Corp.'s (TSE:WELL) Intrinsic Value Is Potentially 60% Above Its Share Price

WELL Health Technologies' (TSE:WELL) Earnings Are Weaker Than They Seem

WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024

WELL Health Technologies Corp. to Report Q1, 2024 Results on May 08, 2024

WELL Health Technologies Corp., Annual General Meeting, Jun 12, 2024

Well Health Technologies Corp. Raises Earnings Guidance for 2024

Full year 2023 earnings released: EPS: CA$0 (vs CA$0.006 in FY 2022)

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

WELL Health Technologies Corp. to Report Q4, 2023 Results on Mar 21, 2024

Is WELL Health Technologies Corp. (TSE:WELL) Trading At A 40% Discount?

Independent Director exercised options and sold CA$144k worth of stock

WELL Health Technologies Corp. Announces the Creation of A Dedicated Public Sector Group to Help Tech Enable Public Health Systems Operating At Scale

Healwell AI Inc. (TSX:AIDX) completed the acquisition of Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

Healwell AI Inc. (TSX:AIDX) entered into an agreement to acquire Intrahealth Systems Limited from WELL Health Technologies Corp. (TSX:WELL) for approximately $24.2 million.

The Price Is Right For WELL Health Technologies Corp. (TSE:WELL)

WELL Health Technologies Corp. announced that it has received CAD 0.074876 million in funding

Well Health Announces Launch of Well Ai Inbox Admin: A Revolutionary Ai-Powered Solution for Clinic Inbox Management

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Well Health Technologies Corp. Provides Earnings Guidance for the Year 2023 and 2024

Consensus EPS estimates upgraded to CA$0.08 loss

WELL Health Technologies Corp. Launches WELL Longevity+ Program

WELL Health Technologies Corp. to Report Q3, 2023 Results on Nov 14, 2023

WELL Health Technologies (TSE:WELL) Seems To Use Debt Quite Sensibly

Independent Director recently sold CA$160k worth of stock

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of Clinic assets from MCI Medical Clinics Inc.

Consensus estimates of losses per share improve by 22%

Second quarter 2023 earnings: EPS exceeds analyst expectations

WELL Health Technologies Corp. to Report Q2, 2023 Results on Aug 10, 2023

Founder exercised options and sold CA$527k worth of stock

WELL Health Technologies Corp. (TSX:WELL) entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc.

Consensus EPS estimates fall by 11%, revenue upgraded

We Think WELL Health Technologies (TSE:WELL) Can Stay On Top Of Its Debt

Consensus EPS estimates fall by 11%, revenue upgraded

Well Health Technologies Corp. Provides Revenue Guidance for the Year 2023

Chief Financial Officer exercised options to buy CA$1.5m worth of stock.

WELL Health Technologies Corp. (TSX:WELL) completed the acquisition of MCI Medical Clinics (Alberta) Inc. from MCI Onehealth Technologies Inc. (TSX:DRDR).

Founder exercised options and sold CA$204k worth of stock